Durvalumab plus platinum–etoposide versus platinum–etoposide in first-line treatment of extensive-stage small-cell lung cancer (CASPIAN): a randomised, controlled, open-label, phase 3 trial
Hospital Universitario 12 De Octubre · Budgetary Health Care Institution of the Omsk Region "Clinical Oncology Center" · +19 more institutions
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
2,164
total citations
- FWCI
- 92.03
- Percentile
- 100%
- References
- 34
Citations per year
Authors
246- LPLuis Paz‐AresCorresponding
Hospital Universitario 12 De Octubre
- MDMikhail Dvorkin
Budgetary Health Care Institution of the Omsk Region "Clinical Oncology Center"
- YCYuanbin Chen
Hematology Oncology Consultants
- NRNiels Reinmuth
Asklepios Fachkliniken München-Gauting
- KHKatsuyuki Hotta
Okayama University Hospital
Topics & keywords
Topics
Keywords
- Etoposide
- Medicine
- Durvalumab
- Platinum
- Oncology
- Stage (stratigraphy)
- Internal medicine
- Cancer
No related works found for this paper.